National Immunisation Programme Redirecting...

This website is organised and funded by GSK. Adverse event reporting and prescribing information can be found below the registration form.

Diabetes, chronic kidney disease and cardiovascular conditions are more prevalent with age, and may increase an individual's risk of shingles, compared to the general population.^1-6

Your patients with these common comorbidities may be eligible for the Shingles National Immunisation Programme due to their age*

Explore illuminate resources for clarity on the eligibility criteria and practical resources designed to support you in helping to protect your eligible patients

* Or due to meeting the definition of Severely Immunocompromised, defined in the Green Book

GOV UK. Research and analysis: Health trends and variation in England, 2025 (accessible version). Published September 2025.
Public Health England. Diabetes Prevalence Model. Published September 2016.
NHS England. Health Survey for England, 2022 Part 2. Published September 2024.
Huang CT, Lee CY, Sung HY, et al. Association between diabetes mellitus and the risk of herpes zoster: a systematic review and meta- analysis. J Clin Endocrinol Metab. 2022;107(2):586–97.
Marra F, Parhar K, Huang B, et al. Risk factors for herpes zoster infection: a meta-analysis. Open Forum Infect Dis. 2020;7(1):ofaa005

Organised and funded by GSK. For UK healthcare professionals. This site contains promotional material.

Register to stay updated with the latest peer-led, practical resources designed to support programme implementation!

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441 or UKSafety@gsk.com.

For the SHINGRIX® (herpes zoster vaccine, recombinant, adjuvanted) prescribing information, click here.